Oncternal Therapeutics Inc (ONCT) — Capital Reinvestment Ratio

Latest as of March 2008: 0.02x

Oncternal Therapeutics Inc (ONCT) has a Capital Reinvestment Ratio of 0.02x as of March 2008, meaning it reinvests 0% of its operating cash flow ($28.70 Million) in capital expenditures ($697.00K). Check Oncternal Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$28.70 Million

USD

Capital Expenditures

$697.00K

USD

Data as of

Mar 2008

Most recent filing

Annual Capital Reinvestment Ratio for Oncternal Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Oncternal Therapeutics Inc from None to None. See Oncternal Therapeutics Inc (ONCT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow